Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

czyli wszystkie giełdy bardziej rozwinięte niż GPW
slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 21 wrz 2021 20:52

J&J says second shot boosts protection for moderate-severe COVID-19 to 94%

CHICAGO (Reuters) - Johnson & Johnson (NYSE:JNJ) said Tuesday a second shot of its COVID-19 vaccine given about two months after the first increased its effectiveness to 94% in the United States against moderate to severe forms of the disease.

That compares to 70% protection with a single dose.

https://www.investing.com/news/stock-ma ... 94-2621842
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!


slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 03 paź 2021 00:09

Europejska Agencja Leków zwraca uwagę na możliwość występowania nowych skutków ubocznych po szczepionce COVID-19. Zdaniem agencji preparat Johnson&Johnson może przyczyniać się do powstawania zakrzepów krwi w żyłach głębokich. Informacja o tym niebawem pojawi się w etykiecie informacyjnej szczepionki.

https://www.msn.com/pl-pl/zdrowie/nasze ... d=msedgntp
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 12 paź 2021 19:53

J&J's chief scientific officer will retire by year end

(Reuters) -Johnson & Johnson said on Tuesday Chief Scientific Officer Paul Stoffels, who spearheaded the development of the company's single-shot COVID-19 vaccine, will retire at the end of this year.

The healthcare conglomerate did not immediately name Stoffels' successor.

Stoffels, 59, began his career as a physician in Africa with a focus on HIV and worked at J&J (NYSE:JNJ)'s Janssen Pharmaceutica in the early 1990s. He re-joined J&J in 2002 when the drugmaker acquired Virco and Tibotec, a Belgium-based antiviral drug developer, to expand its pipeline of HIV drugs.

Chief Scientific Officer since 2012, Stoffels has been responsible for innovation and safety across J&J's drugs, medical devices and consumer health sectors.

"Under Paul's leadership, the Janssen R&D teams developed more than 25 new medicines across multiple therapeutic areas," said Joaquin Duato, J&J's incoming chief executive officer.

In August, J&J named Duato successor to long-standing Chief Executive Officer Alex Gorsky, effective January 3.

During Stoffels' tenure, the drugmaker developed a one-shot vaccine for COVID-19, which won the U.S. regulatory authorization in February. The vaccine's uptake, however, suffered https://www.reuters.com/business/health ... 2021-06-07 due to safety concerns.

Stoffels will also retire from the role of vice chairman of J&J's executive committee.
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 18 paź 2021 13:01

J&J puts talc liabilities into bankruptcy

Oct 14 (Reuters) - Johnson & Johnson (JNJ.N) on Thursday put into bankruptcy tens of thousands of legal claims alleging its Baby Powder and other talc-based products caused cancer, offloading the potential liabilities into a newly created subsidiary.

J&J put the talc claims into an entity called LTL Management LLC, which filed for bankruptcy protection on Thursday in North Carolina, according to the company and court records. J&J and its affiliates were not part of the bankruptcy filing.

Tens of thousands of plaintiffs have alleged J&J's Baby Powder and other talc products contained asbestos and caused cancer, which the company denies. The plaintiffs include women suffering from ovarian cancer and others battling mesothelioma.

J&J executed Thursday's corporate reshuffling through a contentious legal maneuver known as a Texas two-step bankruptcy, a strategy other companies facing asbestos litigation have used.

In that process, a J&J business split in two through a so-called divisional merger under Texas law. That transaction created LTL, the new entity saddled with J&J's talc liabilities, according to court papers filed Thursday.
...
https://www.reuters.com/business/health ... 4ISsEoOxp0
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 19 paź 2021 12:28

Latest Release
Oct 19, 2021

EPS / Forecast
2.6 / 2.36

Revenue / Forecast
23.34B / 23.66B
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 31 paź 2021 20:27

When to buy Johnson & Johnson?
The third piece of content that I wanted to share with you is about the video which I published a week ago. In this video I’m taking a deeper look into Johnson & Johnson.

Many people quote it as the best dividend growth stock of our times due to its clockwork nature, myself included.

But on the other hand I realized the other day that I actually forgot a lot about their business. The last time I really studied the company was probably about 5 years ago and I couldn’t tell you right now what their main catalysts are and why it should continue to grow their dividends.

Hence, it was really time for me again to give it a deeper look to figure out if there’s anything I should change my mind on.

And truth to be told, there were a few interesting insights which have definitely shifted my thinking about Johnson & Johnson going forward.

I just don’t want to put any spoilers here, so if you’re interested then I would definitely recommend to check it out

https://youtu.be/WJ9lpAghMxs

https://europeandgi.com/5-bullet-sunday ... this-blog/
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 12 lis 2021 13:54

J&J Splits Into J And J?
Johnson & Johnson will become two companies. One will include prescription drugs and medical devices, while the other will concentrate on consumer products, such as Band-Aid bandages and Listerine. The consumer-focused firm will retain all liability from lawsuits that older versions of its baby powder caused cancer.

JNJ stock rose 3% before Friday's open.

https://abcnews.go.com/Business/wireSto ... s-81128200
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 14 lis 2021 23:36

Johnson & Johnson spin-off | All you need to know! | Why did they do this and is it any good for us?
europeandgi.com
https://www.youtube.com/watch?v=lg84hqgRD5c
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!

slayer74
Porucznik
Posty: 34787
Rejestracja: 19 lip 2005 13:21
Lokalizacja: West Poland- FZ 1974

Re: Johnson & Johnson J&J NYSE: JNJ leki, medycyna i kosmetyki

Postautor: slayer74 » 18 lis 2021 23:39

Johnson & Johnson (JNJ) Analiza Fundamentalna

https://www.youtube.com/watch?v=OTlD1xsoB1w
Pieniądz robi pieniądz a bieda robi jeszcze wiekszą biedę !!!


Wróć do „Zagranica”

REKLAMA

Kto jest online

Użytkownicy przeglądający to forum: Obecnie na forum nie ma żadnego zarejestrowanego użytkownika i 1 gość